Anjarium Biosciences (private company)
See something wrong or missing? Let us know
Offices:Schlieren
Industry:
Biotech
Health services
Pharma
Business model:
B2B
Anjarium uses science and expertise at the interface of genetic medicine, synthetic biology and nanoparticle engineering to rationally design and produce tissue-targeted gene therapies for a range of serious genetic diseases.
Investors:
we tracked 5 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 59.53m
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom